Clinical Trial Update: The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CKD-497 evaluating efficacy and safety has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• CKD-497

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Respiratory Infection | Phase 2 | Status: COMPLETED